JAZZ PHARMACEUTICALS PLC (JAZZ) Stock Earnings & Estimates
USA - NASDAQ:JAZZ - IE00B4Q5ZN47 - Common Stock
129.02 USD
+2.02 (+1.59%)
129.02 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 3.659B 18.27% | 3.834B 4.78% | 4.069B 6.12% | 4.301B 5.70% | 4.566B 6.16% | 4.887B 7.03% | 5.271B 7.86% | 5.603B 6.30% | 5.559B -0.79% | 5.483B -1.37% | 5.629B 2.66% | |
| EBITDA YoY % growth | 738.4M -22.42% | 1.317B 78.37% | 1.387B 5.29% | 796.97M -42.53% | 1.953B 145.05% | 2.032B 4.05% | 2.375B 16.88% | 2.542B 7.03% | 2.51B -1.26% | 2.143B -14.62% | 2.074B -3.22% | |
| EBIT YoY % growth | 108.9M -72.73% | 678.38M 522.94% | 726.63M 7.11% | 751.08M 3.36% | 1.825B 142.98% | 2.005B 9.86% | 2.027B 1.10% | 2.394B 18.11% | 2.158B -9.86% | 1.647B -23.68% | 1.892B 14.88% | |
| Operating Margin | 2.98% | 17.69% | 17.86% | 17.46% | 39.97% | 41.03% | 38.46% | 42.73% | 38.82% | 30.04% | 33.61% | |
| EPS YoY % growth | 13.13 -19.10% | 18.32 39.53% | 21.19 15.67% | 5.38 -74.63% | 22.22 313.28% | 24.73 11.33% | 25.62 3.58% | 29.55 15.37% | 27.44 -7.15% | 21.21 -22.71% | 23.86 12.52% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 6.09 -7.88% | 5.87 -11.14% | 4.44 164.47% | 5.52 166.96% | 5.87 -3.64% | 5.83 -0.52% |
| Revenue Q2Q % growth | 1.131B 7.21% | 1.187B 9.08% | 993M 10.60% | 1.114B 6.53% | 1.18B 4.33% | 1.234B 3.96% |
| EBITDA Q2Q % growth | 501.81M -33.26% | 489.75M -42.44% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 491.84M 89.02% | 478.18M 150.66% | 409.42M 832.52% | 467.22M 113.37% | 520.4M 5.81% | 537.74M 12.46% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -8.25 -255.66% | -7.76 | -0.49 | -6.35% |
| Q1 2025 Q2Q % growth | 1.68 -37.31% | 4.75 | -3.07 | -64.64% |
| Q4 2024 Q2Q % growth | 6.60 31.47% | 5.93 | 0.67 | 11.32% |
| Q3 2024 Q2Q % growth | 6.61 36.57% | 5.61 | 1.00 | 17.85% |
| Q2 2024 Q2Q % growth | 5.30 17.52% | 4.87 | 0.43 | 8.88% |
| Q1 2024 Q2Q % growth | 2.68 -32.15% | 4.26 | -1.58 | -37.13% |
| Q4 2023 Q2Q % growth | 5.02 7,271.43% | 5.29 | -0.27 | -5.07% |
| Q3 2023 Q2Q % growth | 4.84 -6.38% | 5.03 | -0.19 | -3.79% |
| Q2 2023 Q2Q % growth | 4.51 4.88% | 4.52 | -0.01 | -0.23% |
| Q1 2023 Q2Q % growth | 3.95 5.90% | 4.32 | -0.37 | -8.66% |
| Q4 2022 Q2Q % growth | -0.07 -101.66% | 0.33 | -0.40 | -121.41% |
| Q3 2022 Q2Q % growth | 5.17 23.10% | 4.75 | 0.42 | 8.75% |
| Q2 2022 Q2Q % growth | 4.30 10.26% | 4.28 | 0.02 | 0.58% |
| Q1 2022 Q2Q % growth | 3.73 -4.85% | 3.92 | -0.19 | -4.77% |
| Q4 2021 Q2Q % growth | 4.21 5.25% | 3.72 | 0.49 | 13.31% |
| Q3 2021 Q2Q % growth | 4.20 -2.55% | 3.38 | 0.82 | 24.08% |
| Q2 2021 Q2Q % growth | 3.90 5.12% | 3.50 | 0.40 | 11.45% |
| Q1 2021 Q2Q % growth | 3.92 771.11% | 3.79 | 0.13 | 3.53% |
| Q4 2020 Q2Q % growth | 4.00 -9.50% | 4.29 | -0.29 | -6.69% |
| Q3 2020 Q2Q % growth | 4.31 5.12% | 4.16 | 0.15 | 3.67% |
| Q2 2020 Q2Q % growth | 3.71 -8.40% | 3.17 | 0.54 | 16.86% |
| Q1 2020 Q2Q % growth | 0.45 -87.74% | 0.69 | -0.24 | -34.35% |
| Q4 2019 Q2Q % growth | 4.42 | 4.20 | 0.22 | 5.16% |
| Q3 2019 Q2Q % growth | 4.10 | 3.67 | 0.43 | 11.81% |
| Q2 2019 Q2Q % growth | 4.05 | 3.64 | 0.41 | 11.18% |
| Q1 2019 Q2Q % growth | 3.67 | 3.22 | 0.45 | 13.89% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 1.046B 2.14% | 1.068B | -22.288M | -2.09% |
| Q1 2025 Q2Q % growth | 897.841M -0.46% | 1.005B | -107.159M | -10.66% |
| Q4 2024 Q2Q % growth | 1.088B 7.53% | 1.081B | 7.173M | 0.66% |
| Q3 2024 Q2Q % growth | 1.055B 8.52% | 1.057B | -2.031M | -0.19% |
| Q2 2024 Q2Q % growth | 1.024B 6.95% | 1.024B | -175K | -0.02% |
| Q1 2024 Q2Q % growth | 901.983M 1.03% | 972.97M | -70.987M | -7.30% |
| Q4 2023 Q2Q % growth | 1.012B 4.10% | 1.021B | -9.065M | -0.89% |
| Q3 2023 Q2Q % growth | 972.14M 3.34% | 985.21M | -13.07M | -1.33% |
| Q2 2023 Q2Q % growth | 957.317M 2.62% | 961.72M | -4.403M | -0.46% |
| Q1 2023 Q2Q % growth | 892.812M 9.72% | 913.34M | -20.528M | -2.25% |
| Q4 2022 Q2Q % growth | 972.1M 8.41% | 995.11M | -23.01M | -2.31% |
| Q3 2022 Q2Q % growth | 940.7M 12.24% | 957.84M | -17.14M | -1.79% |
| Q2 2022 Q2Q % growth | 932.9M 24.09% | 922.3M | 10.6M | 1.15% |
| Q1 2022 Q2Q % growth | 813.7M 33.92% | 869.81M | -56.11M | -6.45% |
| Q4 2021 Q2Q % growth | 896.7M 34.74% | 881.51M | 15.19M | 1.72% |
| Q3 2021 Q2Q % growth | 838.1M 39.47% | 849.17M | -11.07M | -1.30% |
| Q2 2021 Q2Q % growth | 751.8M 33.68% | 754.36M | -2.56M | -0.34% |
| Q1 2021 Q2Q % growth | 607.6M 13.63% | 620.41M | -12.81M | -2.06% |
| Q4 2020 Q2Q % growth | 665.5M 14.41% | 652.34M | 13.16M | 2.02% |
| Q3 2020 Q2Q % growth | 600.9M 11.75% | 589.13M | 11.77M | 2.00% |
| Q2 2020 Q2Q % growth | 562.4M 5.30% | 514.75M | 47.65M | 9.26% |
| Q1 2020 Q2Q % growth | 534.7M 5.21% | 555.44M | -20.74M | -3.73% |
| Q4 2019 Q2Q % growth | 581.7M | 573.26M | 8.44M | 1.47% |
| Q3 2019 Q2Q % growth | 537.7M | 534.88M | 2.82M | 0.53% |
| Q2 2019 Q2Q % growth | 534.1M | 518.79M | 15.31M | 2.95% |
| Q1 2019 Q2Q % growth | 508.2M | 475.27M | 32.93M | 6.93% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0.22% | 18.3% | 0.47% | 6.62% |
| Revenue | 0% | 0.27% | 0.05% | -0.32% |